CB1/2 Agonist 1（Cat No.:I043609）is a selective compound that activates both CB1 and CB2 receptors, which are part of the endocannabinoid system. These receptors are involved in regulating a variety of physiological processes, including pain sensation, mood, immune response, and appetite. By activating CB1 and CB2, this compound may offer therapeutic benefits in treating conditions like chronic pain, anxiety, inflammation, and neurodegenerative diseases. Its dual receptor targeting makes it a promising candidate for research into novel treatments that modulate the endocannabinoid system for a range of medical applications.